Skip to content
RARECast cover art

All episodes

RARECast, 618 episodes. Page 6 of 7.

#
Title
501

Innovative Collaboration Model Drives Treatment for Rare Disease

502

Girl with Rare Disease Inspires Search for Bone Marrow Donors

503

A Quest for Tribe: Searching for Others with the Same Ultra-Rare Mutation

504

Raising Awareness in a Town with a History of a Rare Disease

505

Helping Rare Disease Patients Navigate the World of Information

506

Overcoming the Challenges of Rare Disease Drug Development

507

Moving Rare Disease Therapies from Hope to Reality

508

Children’s National Launches First-of-its-Kind Rare Disease Center

509

A Common Link in a Group of Rare Diseases Creates an Opportunity for Repurposing

510

Sobi Works to Expand Rare Disease Indications for Its Drugs

511

Why Rare Disease Patients Should Work Together to Address Common Concerns

512

Solving Medical Mysteries with the Wisdom of Crowds

513

Embracing Collaborations to Drive Development of Rare Disease Therapies

514

Determining If a Child's Neurologic or Psychiatric Symptoms are Caused by an Infection

515

Helping Patients with the Same Undiagnosed Genetic Condition Find Each Other

516

An Entrepreneur Uses a Silicon Valley Approach to Tackle Rare Disease

517

Looking for Love with a Rare Disease

518

Why Genomics May Be in Google's DNA

519

The Power of Small Grants to Make Big Impacts

520

Building an International Registry for Rare Diseases

521

Discovering the Creative Use of Outrage

522

Diagnosing Rare Diseases with Facial Analysis

523

Charles River Sees Opportunity in Fostering Rare Disease Collaborations

524

Abeona Advancing Pipeline of Gene Therapies for Rare Diseases

525

A Patient Attends "an Academic Conference for Everyone"

526

Teen Advocate Preaches Message of Kindness

527

A Controversial Approval for a Duchenne Drug and What's Ahead

528

Matchmaker Exchange Helps Rare Disease Community Find Me a Find

529

The Promise of RNAi for Hereditary Angioedema and Other Rare Diseases

530

Why Natural History Studies Matter to Rare Disease Patients

531

Harnessing Big Data to Work for Rare Disease Patients

532

Lessons from Autism on Accelerating Drug Development

533

How One Rare Disease Group Leverages Relationships with Industry

534

Ice Bucket Challenge Begins to Yield Results

535

Why a Common Diabetes Drug May Be Able to Treat a Rare Disease

536

How to Improve Patient Access to Experimental Drugs

537

Using Social Media to Find Rare Disease Patients for Clinical Trials

538

How Rare Disease Patients Weigh Risks and Benefits of a Therapy

539

Why Homology Medicines Might Be a Game Changer for Gene Therapy

540

Orchard Hopes to Bear the Fruit of Gene Therapy

541

Novel Approach to Treat Rare Disease May Lead to Drugs for Common Ones

542

Brining Whole Genome Sequencing into the Clinic

543

Bringing Patient-Centricity to Clinical Trials

544

Determining If a Child's Neurologic or Psychiatric Symptoms are Caused by an Infection

545

Making Genetic Data Accessible to Researchers

546

How New Sequencing Technology Is Changing Our Understanding of Rare Diseases

547

Marathon Readies DMD Drug for FDA

548

Searching for Genes They May Protect Against Deadly Diseases

549

Helping Patients with the Same Undiagnosed Genetic Condition Find Each Other

550

Living with a Disease in Search of a Name

551

New Means of Regulating Genes May Hold Promise for Rare Disease Patients

552

Invitae Seeks a Faster, Cheaper Path to Diagnosing Genetic Diseases

553

Filmmaker Turns Lens on the Rare Disease Community

554

The Case for Keeping Orphans Where They Can Thrive

555

Rare Disease Legislation Advancing at National, State Level

556

The Evolving Relationship Between Patient Advocates and Pharma

557

Phil Reilly on The Quest to Save Children with Rare Genetic Disorders

558

Unlocking the Genetic Mysteries of Rare Diseases

559

A Vision for Making Kansas City a Rare Disease Center of Excellence

560

A Push in Canada for a National Rare Disease Strategy

561

Jazzed in Utah for World Rare Disease Day

562

Group Aims to Accelerate Repurposing of Drugs to Treat Rare Diseases

563

Gene Therapies Bring New Hope to Rare Disease Patients

564

Why Rare Disease Research Should Matter to Everyone

565

Researchers Say Reform of the Orphan Drug Act is Needed

566

Looking for Love with a Rare Disease

567

Gene Editing Tool Holds Promise in Rare Disease Treatments

568

A Cross Country Quest for Marrow Donors

569

Building Strength by Sharing Stories

570

North Carolina Seeks Leadership Role in Combating Rare Diseases

571

The Power of Small Grants to Make Big Impacts

572

Tearing Down Differences with Film

573

Educating Docs to Improve Diagnosis and Treatment of Genetic Metabolic Diseases

574

Providing Young Adult Cancer Patients and Survivors Resources They Need

575

Gene Therapy Company Born from Mother's Quest to Cure Daughter

576

Accelerating Rare Disease Research through Collaboration

577

Cracking the Genetics of Rare Diseases through Crowdsourcing

578

Teen Advocate to World: "We are More than Our Diseases"

579

Why the 21st Century Cures Act May Be in Trouble in the Senate

580

How Lisa Bentley Became a World Class Triathlete with Cystic Fibrosis

581

Understanding the Rare Disease Caregiver

582

Addressing Life-Threatening Rare Diseases with Gene Therapy

583

Living with, Rather Than for, a Rare Disease

584

An Entrepreneur Uses a Silicon Valley Approach to Tackle Rare Disease

585

Chronicling the Genomic Revolution

586

How a Radio Personality Became a Rare Disease Advocate

587

Why Genomics May Be in Google's DNA

588

An FDA Perspective on Rare Diseases

589

Helping Patients Take Control of Their Healthcare

590

Living Life Beyond Limits

591

Noah Coughlan Completes His 3,000 Mile Trek for Rare Diseases

592

How the 21st Century Cures Act Puts Patients at the Table

593

Using Cell and Gene Therapies to Treat Rare Skin Diseases

594

Incentives Boost Innovation in Rare Disease Therapies

595

Tensions Brew Between Pharma and Patient Advocacy Groups

596

The Attraction of Being a Rare Disease Drug Company

597

Confronting Genetic Destiny in The Lion's Mouth Opens

598

Royal Pains Throws Spotlight on Rare Diseases

599

Making the Case Rare Diseases are Fundamental

600

Programming the Immune System to Produce Drugs